Ads

You May Also Like

XBiotech Provides Update on Phase III Oncology Study in Europe

AUSTIN, Texas, Nov. 23, 2015 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ:XBIT), developer of True Human™ ...

ViroGates Announces Its First International Clinical Customer

Company announcement no. 5-2018 Birkerød, 31 July 2018 ViroGates Announces Its First International Clinical ...